Sort by

Send to

Choose Destination

Search results

Items: 3


Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy.

Driehuis E, Kolders S, Spelier S, Lõhmussaar K, Willems SM, Devriese LA, de Bree R, de Ruiter EJ, Korving J, Begthel H, van Es JH, Geurts V, He GW, van Jaarsveld RH, Oka R, Muraro MJ, Vivié J, Zandvliet MMJM, Hendrickx APA, Iakobachvili N, Sridevi P, Kranenburg O, van Boxtel R, Kops GJPL, Tuveson DA, Peters PJ, van Oudenaarden A, Clevers H.

Cancer Discov. 2019 Jul;9(7):852-871. doi: 10.1158/2159-8290.CD-18-1522. Epub 2019 May 3.


The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

de Ruiter EJ, Ooft ML, Devriese LA, Willems SM.

Oncoimmunology. 2017 Aug 9;6(11):e1356148. doi: 10.1080/2162402X.2017.1356148. eCollection 2017. Review.


PTK2/FAK: a new predictive biomarker for response to radiotherapy in head and neck squamous cell carcinoma.

de Ruiter EJ, Willems SM.

Ann Transl Med. 2016 Oct;4(Suppl 1):S44. No abstract available.

Supplemental Content

Loading ...
Support Center